About the Journal

The “Meyafarqin Medical Journal (Meyafarqin Med J.)" (eISSN 2979-9783) is an independent peer-reviewed, double-blind, open-access international general medical journal founded in April 2022. It is published three times a year (April, August and December). This journal publishes only Reviews such as Narrative Review, Mini Review, Systematic Review, and Meta-Analysis. Articles are selected and published following a rigorous analysis, according to internationally accepted standards. The journal is open to scholars, as well as all members of the medical community, expressing interest in using this forum to publish their work. The official language is English.

 

The Editorial Board of the JCTEI adheres to the principles of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the US National Library of Medicine (NLM), and the World Medical Association (WMA).

 

Average time;

Submission to first decision without review: 7 days

Submission to review (Median): 14 days

Acceptance to publication (Median):  30 days